top of page

National BTC Multidisciplinary Rounds (BTC MDR)

The C3 organizes and hosts the only nation-wide Multidisciplinary rounds for Biliary Tract Cancers (BTC) in Canada. The BTC MDR is open to all physicians and trainees involved in the care of Biliary tract cancers. We accept requests for presentation at rounds from surgeons and oncologists across the country and patients are allowed to request their case to be presented for specific questions as well. Please note that NO PATIENTS OR INDUSTRY can attend these meetings.

Key Points:

  • Monthly virtual meeting held on Microsoft Teams

  • Chaired by Dr. Rebecca Auer and Dr. Rachel Goodwin 

  • Dedicated pathologist, radiologist, and molecular oncologist 

  • Treating medical oncologist or the patient can list the case (in latter case the oncologist will be notified and encouraged to come to the rounds but patients are not invited to rounds)

  • An official C3 report summary is provided to the patient and treating physician following their case presentation

  • Self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada

Objectives:

  • Provide a multidisciplinary national forum to discuss complex BTC cases to facilitate diagnostic and treatment decisions, including identification of patients for relevant clinical research studies.

  • Review molecular testing and diagnostic options for patients with molecular profiling on their tumour.

  • Create a forum for exchange of knowledge, perspective and experience between professionals and centres regarding best practice and innovations in diagnosis, treatment and prognosis of BTC.

  • Provide an educational opportunity for learners across all disciplines.

Have a patient case you would like presented?  

C3 BTC MDR Schedule​​

Meeting Date
Presenter
Meeting Topic
January 30, 2025
TBD
TBD
February 27, 2025
TBD
TBD
March 27, 2025
TBD
TBD
April 24, 2025
TBD
TBD
May 22, 2025
TBD
TBD
June 19, 2025
TBD
TBD
October 9, 2025
TBD
TBD
November 6, 2025
TBD
TBD
December 4, 2025
TBD
TBD
  • Instagram
  • Facebook
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

Le Collectif Canadien pour le cholangiocarcinome (C3) est financé par une subvention d'équipe révolutionnaire de la Société Canadienne du cancer en partenariat avec les Instituts de recherche en santé du Canada. Les fonds de la subvention pour le C3 sont gérés par l'Institut de recherche de l'Hôpital d'Ottawa, qui sert d'institut principal pour toutes les opérations collaboratives.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page